Melanoma (Skin) research hub

Tebentafusp in Molecular Relapsed Disease (MRD) Melanoma

This study looks at using a new blood test to help decide when to give a drug called tebentafusp to people with certain types of melanoma that have been treated but could come back. The aim is to see if tebentafusp can help them live longer.